| Xing, Chengguo |
University Of Florida
United States |
Quantifying NNK metabolites to facilitate Kava lung cancer prevention clinical translation |
5R03CA273467-02 |
|
|
| Tollefsbol, Trygve O |
University Of Alabama At Birmingham
United States |
Combinatorial epigenetic-based prevention of breast cancer |
5R01CA178441-09 |
|
|
| Tangen, Catherine M. |
Fred Hutchinson Cancer Center
United States |
PCPT and SELECT Cohorts: Core Infrastructure Support for Cancer Research |
5U01CA182883-11 |
|
Howard L. Parnes, M.D. |
| Schmidt, Christian Maximillian |
Indiana Univ-Purdue Univ At Indianapolis
United States |
Longitudinal Proteomic and Metabolomic Predictors of Pancreatic Cyst Malignant Progression and Early Stage Pancreatic Cancer |
5U01CA239522-04 |
PAR-18-913 (U01 Clinical Trial Not Allowed) |
Claire Zhu, Ph.D. |
| Largaespada, David Andrew |
University Of Minnesota
United States |
Recurrent Tumor-Specific Alternately Processed Transcripts as a Source of Neoantigens for NF1-associated Malignant Peripheral Nerve Sheath Tumor Immunoprevention |
5UH3CA244687-05 |
RFA-CA-19-012 |
Mark Steven Miller, Ph.D. |
| Zhu, Yong |
Univ Of Arkansas For Med Scis
United States |
Explore piRNAs as a novel group of biomarkers for ovarian cancer early detection |
1R21CA277412-01A1 |
|
Christos Patriotis, Ph.D., M.Sc. |
| Altorki, Nasser Khaled |
Weill Medical Coll Of Cornell Univ
United States |
Intercepting progression from pre-invasive to invasive lung adenocarcinoma |
3UH3CA244697-05S1 |
|
Mark Steven Miller, Ph.D. |
| Boyer, Thomas G |
University Of Texas Hlth Science Center
United States |
Pathological reprogramming of the m6A epitranscriptome in uterine fibroids |
5R01HD106285-03 |
|
|
| Curiel-Lewandrowski, Clara |
University Of Arizona
United States |
Targeted Prevention for Non-Melanoma Skin Cancer |
5P01CA229112-05 |
PAR-18-290 (P01 Clinical Trial Optional) |
Winfred Malone, Ph.D., M.P.H. |
| Fabian, Carol J |
University Of Kansas Medical Center
United States |
Biomarker-Based Phase IIB Trial of (Bazedoxifene-Conjugated Estrogen) to Reduce Risk for Breast Cancer |
5R01CA249437-03 |
|
Edward Sauter, M.D., Ph.D. |